looks like its been a good meeting in WA. There are over 230m HepC cases in the world today. The important thing about these diagnostic kits is that they test people that dont even have the disease. This greatly increases the size of the market. The other thing these guys have going for them is that the technology platform they have can cross over into other diseases. This means that they can develop kits for other problems.this could be one of the big diagnostic companies in the making.good luck.
SLT Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
